Relationship of ganciclovir therapeutic drug monitoring with clinical efficacy and patient safety

Keyphrases

• Clinical Efficacy 100%
• Clinical Patients 100%
• Safety Self-efficacy 100%
• Patient Safety 100%
• Ganciclovir 100%
• Therapeutic Drug Monitoring 100%
• Viral Load 40%
• Safety Endpoints 30%
• Cytomegalovirus 20%
• Symptomatology 20%
• Peak Concentration 20%
• Cytomegalovirus Infection 20%
• Efficacy Endpoint 20%
• Monitoring Efficacy 20%
• Clinical Utility 10%
• Neurotoxicity 10%
• Pharmacodynamics 10%
• Specific Populations 10%
• Pharmacokinetic Profile 10%
• Anemia 10%
• Adult Patients 10%
• Trough Concentration 10%
• Leukopenia 10%
• Neutropenia 10%
• Thrombocytopenia 10%
• Nephrotoxicity 10%
• Limit of Quantification 10%
• Efficacy Outcomes 10%
• Limited Value 10%
• Clinical Safety 10%
• Cytomegalovirus Viremia 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Ganciclovir 100%
• Therapeutic Drug Monitoring 100%
• Cytomegalovirus 30%
• Symptomatology 20%
• Cytomegalovirus Infection 20%
• Neurotoxicity 10%
• Pharmacodynamics 10%
• Viremia 10%
• Anemia 10%
• Neutropenia 10%
• Thrombocytopenia 10%
• Leukopenia 10%
• Nephrotoxicity 10%
• Pharmacokinetics 10%

Immunology and Microbiology

• Viral Load 100%
• Cytomegalovirus 75%
• Cytomegalovirus Infection 50%
• Pharmacokinetics 25%
• Viremia 25%
• Pharmacodynamics 25%